Multimedia Release

Candidate Cancer Drug Triggers Stress to Kill Solid and Blood Cancer Cells (2 of 3)

Reports and Proceedings

American Association for the Advancement of Science (AAAS)

Candidate Cancer Drug Triggers Stress to Kill Solid and Blood Cancer Cells (2 of 3)

image: This image shows the structure and mechanism of action of ONC201. ONC201 induces apoptosis through TRAILdependent and TRAIL-independent pathways. In the TRAIL-dependent pathway, ONC201 inhibits AKT and MEK, resulting in the dephosphorylation and nuclear translocation of FOXO3a, which increases transcription of the gene encoding TRAIL. The cells then die by activation of the TRAIL DRs. In the TRAIL-independent pathway, ONC201 induces a stress response by an unknown mechanism. Although the mechanisms of the stress response that are activated appear to be different between solid tumors and hematological malignancies, ATF4 appears to be a common player in these tumor types. This material relates to a paper that appeared in the Feb. 16, 2016 issue of Science Signaling, published by AAAS. The paper, by Y.E. Greer at National Cancer Institute, National Institutes of Health in Bethesda, MD, and colleagues was titled, "ONC201: Stressing tumors to death." view more 

Credit: Y.E. Greer / <i>Science Signaling</i> (2016)


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.